Candriam SCA’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.4M | Sell |
396,636
-58,014
| -13% | -$1.82M | 0.07% | 216 |
|
|
2025
Q1 | $15.3M | Sell |
454,650
-37,531
| -8% | -$1.26M | 0.1% | 193 |
|
|
2024
Q4 | $19.3M | Buy |
492,181
+28,320
| +6% | +$1.11M | 0.11% | 169 |
|
|
2024
Q3 | $18.3M | Sell |
463,861
-57,975
| -11% | -$2.28M | 0.1% | 192 |
|
|
2024
Q2 | $20.3M | Sell |
521,836
-39,048
| -7% | -$1.52M | 0.12% | 166 |
|
|
2024
Q1 | $24.1M | Buy |
560,884
+30,000
| +6% | +$1.29M | 0.15% | 143 |
|
|
2023
Q4 | $24.5M | Sell |
530,884
-39,000
| -7% | -$1.8M | 0.17% | 132 |
|
|
2023
Q3 | $19.5M | Sell |
569,884
-136,000
| -19% | -$4.65M | 0.14% | 147 |
|
|
2023
Q2 | $27.2M | Sell |
705,884
-13,322
| -2% | -$513K | 0.2% | 131 |
|
|
2023
Q1 | $23.7M | Sell |
719,206
-16,678
| -2% | -$549K | 0.16% | 143 |
|
|
2022
Q4 | $29M | Sell |
735,884
-25,000
| -3% | -$986K | 0.2% | 123 |
|
|
2022
Q3 | $27.5M | Sell |
760,884
-102,256
| -12% | -$3.69M | 0.19% | 118 |
|
|
2022
Q2 | $26.3M | Buy |
863,140
+258,886
| +43% | +$7.87M | 0.22% | 108 |
|
|
2022
Q1 | $18.5M | Buy |
604,254
+73,743
| +14% | +$2.25M | 0.13% | 176 |
|
|
2021
Q4 | $16.6M | Sell |
530,511
-185,211
| -26% | -$5.79M | 0.11% | 197 |
|
|
2021
Q3 | $10.9M | Hold |
715,722
| – | – | 0.07% | 260 |
|
|
2021
Q2 | $13.3M | Buy |
+715,722
| New | +$13.3M | 0.09% | 244 |
|